| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6829941 | Seizure | 2018 | 5 Pages |
Abstract
Our results suggest that the CB2 receptor agonists might be clinically useful as an adjunct treatment against seizure spread and status epilepticus and concomitant oxidative stress, neurotoxicity and cognitive impairments.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Jana Tchekalarova, Keylla da Conceição Machado, Antonio Luiz Gomes Júnior, Ana Amélia de Carvalho Melo Cavalcante, Albena Momchilova, Rumyana Tzoneva,